Intrauterine Contraceptive Devices Market

Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman?s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.

Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
Intrauterine Contraceptive Devices Market aims to provide a comprehensive presentation of the global market for Intrauterine Contraceptive Devices (IUCD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrauterine Contraceptive Devices (IUCD). Intrauterine Contraceptive Devices Market contains market size and forecasts of Intrauterine Contraceptive Devices (IUCD) in global, including the following market information:
Global Intrauterine Contraceptive Devices (IUCD) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Intrauterine Contraceptive Devices (IUCD) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Intrauterine Contraceptive Devices (IUCD) companies in 2022 (%)
The global Intrauterine Contraceptive Devices (IUCD) market was valued at US$ 3279 million in 2022 and is projected to reach US$ 3793.9 million by 2029, at a CAGR of 2.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-hormonal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intrauterine Contraceptive Devices (IUCD) include Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International and Melbea AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intrauterine Contraceptive Devices (IUCD) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intrauterine Contraceptive Devices (IUCD) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intrauterine Contraceptive Devices (IUCD) Market Segment Percentages, by Type, 2022 (%)
Non-hormonal
Hormonal
Inert
Global Intrauterine Contraceptive Devices (IUCD) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intrauterine Contraceptive Devices (IUCD) Market Segment Percentages, by Application, 2022 (%)
T Shapes
V Shapes
Others
Global Intrauterine Contraceptive Devices (IUCD) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Intrauterine Contraceptive Devices (IUCD) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intrauterine Contraceptive Devices (IUCD) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Intrauterine Contraceptive Devices (IUCD) revenues share in global market, 2022 (%)
Key companies Intrauterine Contraceptive Devices (IUCD) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Intrauterine Contraceptive Devices (IUCD) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intrauterine Contraceptive Devices (IUCD), market overview.
Chapter 2: Global Intrauterine Contraceptive Devices (IUCD) market size in revenue and volume.
Chapter 3: Detailed analysis of Intrauterine Contraceptive Devices (IUCD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intrauterine Contraceptive Devices (IUCD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intrauterine Contraceptive Devices (IUCD) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.